Synthetic and biological identities of layered double hydroxides nanocarriers functionalized with risedronate
Source abstract
Abstract
Layered double hydroxide nanoparticles (LDH-NP) provide new therapeutic opportunities to improve drug distribution, stability, and effectivity. Nevertheless, these LDH-NP present a different behavior in biological medium due to their interaction with biomolecules (biological identity) to that of as-synthesized LDH-NP (synthetic identity). In this work, both identities were compared for LDH-NP functionalized with risedronate. First, physical interactions between as-synthesized LDH-NP and the cell membrane were studied using giant unilamellar vesicles (GUVs). Then, their biological identity was formed in bovine fetal serum and explored with a proteomic approach and the mapping of protein-protein interactions. Finally, the effect of functionalization and biological identity on drug delivery capacity was tested in methotrexate loaded LDH-NP. As a result of their opposite zeta potential , bare LDH-NP (ζ > +40 mV) increased the permeability of the negatively charged GUVs, while Ris functionalized LDH-NP (ζ < −40 mV) showed a much lower permeability increase. Also, a heavily interconnected protein corona with more than 70 different proteins was formed on bare LDH-NP while the number and interconnection of the proteins in the corona were diminished on Ris functionalized ones. Also, Ris functionalization only slightly diminished the drug loading capacity of the nanocarriers, which nevertheless showed a significant cytotoxic effect associated to the intercalated drug.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · Mesoporous Materials and Catalysis · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Nanomaterials for cancer therapy and imaging10.1007/s10059-011-0051-5 ↗
2. Dynamic equilibrium in the cetyltrimethylammonium bromide-Au nanoparticle bilayer, and the consequent impact on the formation of the nanoparticle protein corona10.1021/acs.bioconjchem.9b00624 ↗
3. Risedronate functionalized layered double hydroxides nanoparticles with bone targeting capabilities10.1016/j.clay.2017.03.001 ↗
4. Therapeutic nanoparticles for drug delivery in cancer10.1158/1078-0432.CCR-07-1441 ↗
5. Engineering small MgAl-layered double hydroxide nanoparticles for enhanced gene delivery10.1016/j.clay.2014.04.028 ↗
6. ‘Smart’ nanoparticles as drug delivery systems for applications in tumor therapy10.1517/17425247.2015.1071352 ↗
7. Nanoparticle behaviour in complex media: Methods for characterizing physicochemical properties, evaluating protein corona formation, and implications for biological studies10.1007/978-3-030-12461-8_5 ↗
8. Influence of buffer solutions in the adsorption of human serum proteins onto layered double hydroxide10.1016/j.ijbiomac.2017.08.040 ↗
9. Pre-coating layered double hydroxide nanoparticles with albumin to improve colloidal stability and cellular uptake10.1039/C5TB00248F ↗
10. Directing the nanoparticle formation by the combination with small molecular assembly and polymeric assembly for topical suppression of ocular inflammation10.1016/j.ijpharm.2018.09.015 ↗
11. Overcoming multidrug resistance through co-delivery of ROS-generating nano-machinery in cancer therapeutics10.1039/C6TB03146C ↗
12. Nanotechnology: a focus on nanoparticles as a drug delivery system10.1007/s11481-006-9032-4 ↗
13. Innovations in sustained release drug delivery system and its market opportunities
14. Biodegradable polymeric nanoparticles based drug delivery systems10.1016/j.colsurfb.2009.09.001 ↗
15. Layered double hydroxide nanoparticles to enhance organ-specific targeting and the anti-proliferative effect of cisplatin10.1039/C4TB01989J ↗
16. Layered double hydroxide nanoparticles for biomedical applications: Current status and recent prospects10.1016/j.clay.2015.04.018 ↗
17. Interactions between giant unilamellar vesicles and charged core - shell magnetic nanoparticles10.1021/la1023746 ↗
18. Subcellular performance of nanoparticles in cancer therapy10.2147/IJN.S226186 ↗
19. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells10.1016/j.chemosphere.2019.125624 ↗
20. Electroformation of giant unilamellar vesicles: Investigating vesicle fusion versus bulge merging10.1021/acs.langmuir.6b01679 ↗
21. Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics10.1016/j.ijpharm.2007.04.036 ↗
22. Protein bio-corona: critical issue in immune nanotoxicology10.1007/s00204-016-1797-5 ↗
23. Inorganic drug-delivery nanovehicle conjugated with cancer-cell-specific ligand10.1002/adfm.200801127 ↗
24. Biodegradable nanoparticles for drug and gene delivery to cells and tissue10.1016/j.addr.2012.09.023 ↗
25. Aggregation of layered double hydroxide nanoparticles in the presence of heparin: Towards highly stable delivery systems10.1039/C5RA26072H ↗
26. Biomolecular corona on nanoparticles: A survey of recent literature and its implications in targeted drug delivery10.3389/fchem.2014.00108 ↗
27. The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome10.1039/C6NR04765C ↗
28. Layered double hydroxides as drug carriers and for controlled release of non-steroidal antiinflammatory drugs (NSAIDs): A review10.1016/j.jconrel.2013.03.034 ↗
29. Intercalation of drugs in layered double hydroxides and their controlled release: A review10.1016/j.clay.2013.12.002 ↗
30. Modeling drug release from a layered double hydroxide-ibuprofen complex10.1016/j.clay.2012.04.004 ↗
31. Protein adsorption onto nanoparticles induces conformational changes: Particle size dependency, kinetics, and mechanisms10.1002/elsc.201500059 ↗
32. Schöttler · 2016 · 8806
33. Tailoring hybrid layered double hydroxides for the development of innovative applications
34. Synthesis of methotrexatum intercalated layered double hydroxides by different methods: Biodegradation process and bioassay explore10.1016/j.clay.2015.09.007 ↗
35. A systematic approach to the synthesis of LDH nanoparticles by response surface methodology10.1016/j.clay.2016.12.023 ↗
36. Relevance of protein-protein interactions on the biological identity of nanoparticles10.1016/j.colsurfb.2018.03.032 ↗
37. Pros and cons of coating layered double hydroxide nanoparticles with polyacrylate10.1016/j.clay.2019.02.016 ↗
38. A closer look into the physical interactions between lipid membranes and layered double hydroxide nanoparticles10.1016/j.colsurfb.2020.110998 ↗
39. What the cell “sees” in bionanoscience10.1021/ja910675v ↗
40. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment10.1039/C1CS15233E ↗
41. A Gd-doped Mg-Al-LDH/Au nanocomposite for CT/MR bimodal imagings and simultaneous drug delivery10.1016/j.biomaterials.2013.01.070 ↗
42. Methotrexate intercalated layered double hydroxides with different particle sizes: Structural study and controlled release properties10.1016/j.colsurfb.2014.02.018 ↗